locally advanced rectal and sigmoid cancers
Showing 1 - 25 of >10,000
Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)
Not yet recruiting
- Rectal Cancer
- CapeOX + cetuximab
- +2 more
- (no location specified)
Sep 12, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 5, 2023
Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)
Recruiting
- Rectal Neoplasms
- Rectal Neoplasm Malignant
- Niraparib
- +2 more
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),
Active, not recruiting
- Rectal Cancer
- Locally Advanced
- Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
- Radiotherapy
-
Tunis, TunisiaAmel Mezlini
May 19, 2023
MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)
Not yet recruiting
- MSS
- Rectal Cancer
- Sintilimab with Interleukin-2
- (no location specified)
Nov 1, 2023
Rectal Cancer, Self Efficacy Trial in Boston (PATHWAYS, Enhanced usual care)
Not yet recruiting
- Rectal Cancer
- Self Efficacy
- PATHWAYS
- Enhanced usual care
-
Boston, MassachusettsMassachusetts General Hospital
Jun 22, 2023
Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)
Not yet recruiting
- Locally Advanced Rectal Cancer
- capecitabine
- +3 more
-
Beijing, China
- +1 more
Sep 21, 2023
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
Neoadjuvant Envafolimab in Resectable and Locally Advanced
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- MSI-High
- (no location specified)
Dec 9, 2022
Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)
Not yet recruiting
- Colorectal Cancer
- Serplulimab + FOLFOXIRI
- Radiation therapy
- (no location specified)
Oct 24, 2023
Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)
Not yet recruiting
- Colon Cancer
- Immunotherapy
-
Chongqing, ChinaDaping hospital
Apr 16, 2023
Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy
Recruiting
- Locally Advanced Rectal Cancer
- Locally Recurrent Rectal Cancer
- Intraoperative Electron Radiotherapy (IOERT)
- Extended Margin Surgery
-
Southampton, Hampshire, United KingdomUniversity Hospital Southampton NHS Foundation Trust
May 24, 2023
Rectal Cancer Trial in Chengdu (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Fruquintinib
- +3 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Mar 8, 2023
Evaluation of Inflammatory Markers in LARC Patients
Completed
- Locally Advanced Rectal Cancer
- Inflammatory markers
- (no location specified)
Jun 8, 2023
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and
Not yet recruiting
- Colorectal Neoplasms
-
Beijing, Xicheng Dis, ChinaBeijing Friendship Hospital, Capital medical University
Sep 5, 2023
Rectal Cancer Trial (Ketogenic Diet, Standard Diet)
Not yet recruiting
- Rectal Cancer
- Ketogenic Diet
- Standard Diet
- (no location specified)
Jul 3, 2023
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced
- +3 more
- Toripalimab
- +3 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital Southern Medical University
May 17, 2023
MRI T1 Relaxation Time in Rectal Cancer
Recruiting
- Rectal Cancer
- Locally Advanced Rectal Carcinoma
-
Vejle, Jylland, DenmarkVejle Hospital
May 16, 2023
The Neutrophil To Lymphocyte Ratio In Locally Advanced Rectal
Not yet recruiting
- the Prognostic Value of Pre-treatment NLR in Patients With Locally Advenced Rectal Cancer and Post-treatment
- (no location specified)
Jan 4, 2023
GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY
Not yet recruiting
- Salivary Gland Cancer
- Observation
- (no location specified)
Oct 13, 2023
Rectal Cancer Trial in Fuzhou (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- split-course hypofraction radiotherapy
- +3 more
-
Fuzhou, Fujian, ChinaPan Chi
Jul 23, 2023
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023